Search Results

There are 4661 results for: content related to: In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones

  1. You have free access to this content
    Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)

    Intervention Review

    The Cochrane Library

    Lilia E Ziganshina, Albina F Titarenko and Geraint R Davies

    Published Online : 6 JUN 2013, DOI: 10.1002/14651858.CD004795.pub4

  2. Sequential intravenous/oral moxifloxacin monotherapy for complicated skin and skin structure infections: a meta-analysis of randomised controlled trials

    International Journal of Clinical Practice

    Volume 67, Issue 9, September 2013, Pages: 834–842, F. Chen, N. Zheng, Y. Wang, J. L. Wen, W. F. Tu, Y. Q. Du and J. M. Lin

    Version of Record online : 16 AUG 2013, DOI: 10.1111/ijcp.12174

  3. Pharmacokinetics and Pharmacodynamics of Three Moxifloxacin Dosage Forms: Implications for Blinding in Active-Controlled Cardiac Repolarization Studies

    The Journal of Clinical Pharmacology

    Volume 50, Issue 11, November 2010, Pages: 1249–1259, Dr Jay W. Mason, Dr Jeffry A. Florian Jr, Dr Christine E. Garnett, Dr Thomas E. Moon, Mr Daniel S. Selness and Mr Randol R. Spaulding

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009356298

  4. Moxifloxacin-Containing Triple Therapy versus Bismuth-Containing Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis


    Volume 16, Issue 2, April 2011, Pages: 131–138, Cheng Wu, Xiao Chen, Jing Liu, Ming-Yang Li, Zi-Qi Zhang and Zhi-Qiang Wang

    Version of Record online : 16 MAR 2011, DOI: 10.1111/j.1523-5378.2011.00826.x

  5. You have free access to this content
    Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin

    Clinical Microbiology and Infection

    Volume 8, Issue 6, June 2002, Pages: 373–380, C. L. Clark, K. Nagai, T. A. Davies, B. Bozdogan, B. Dewasse, M. R. Jacobs and P. C. Appelbaum

    Version of Record online : 27 JUN 2002, DOI: 10.1046/j.1469-0691.2002.00405.x

  6. Drug–drug interactions between moxifloxacin and rifampicin based on pharmacokinetics in vivo in rats

    Biomedical Chromatography

    Lifei Huang, Jiajun Liu, Xin Yu, Lei Shi, Jian Liu, Heping Xiao and Yi Huang

    Version of Record online : 28 APR 2016, DOI: 10.1002/bmc.3726

  7. Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials

    International Journal of Clinical Practice

    Volume 66, Issue 2, February 2012, Pages: 210–217, Y. P. Mu, R. L. Liu, L. Q. Wang, X. Deng, N. Zhu, M. D. Wei and Y. Wang

    Version of Record online : 19 JAN 2012, DOI: 10.1111/j.1742-1241.2011.02839.x

  8. You have free access to this content
    Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes

    British Journal of Pharmacology

    Volume 165, Issue 2, January 2012, Pages: 467–478, L Nalos, R Varkevisser, MKB Jonsson, MJC Houtman, JD Beekman, R van der Nagel, MB Thomsen, G Duker, P Sartipy, TP de Boer, M Peschar, MB Rook, TAB van Veen, MAG van der Heyden and MA Vos

    Version of Record online : 16 DEC 2011, DOI: 10.1111/j.1476-5381.2011.01558.x

  9. Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis

    The Laryngoscope

    Volume 120, Issue 5, May 2010, Pages: 1057–1062, James A. Hadley, Ralph Mösges, Martin Desrosiers, Daniel Haverstock, David van Veenhuyzen and Zeljka Herman-Gnjidic

    Version of Record online : 18 FEB 2010, DOI: 10.1002/lary.20878

  10. Benefits of adjunctive moxifloxacin in generalized aggressive periodontitis: a subgroup analyses in Aggregatibacter actinomycetemcomitans-positive/negative patients from a clinical trial

    Journal of Investigative and Clinical Dentistry

    Carlos M. Ardila and Isabel C. Guzmán

    Version of Record online : 5 NOV 2015, DOI: 10.1111/jicd.12197

  11. Weighing the adverse cardiac effects of fluoroquinolones: A risk perspective

    The Journal of Clinical Pharmacology

    Volume 55, Issue 11, November 2015, Pages: 1198–1206, Raman Mehrzad and Michael Barza

    Version of Record online : 18 AUG 2015, DOI: 10.1002/jcph.553

  12. Moxifloxacin-Containing Triple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate


    Volume 14, Issue 5, October 2009, Pages: 429–437, Hyuk Yoon, Nayoung Kim, Byoung Hwan Lee, Tae Jun Hwang, Dong Ho Lee, Young Soo Park, Ryoung Hee Nam, Hyun Chae Jung and In Sung Song

    Version of Record online : 9 SEP 2009, DOI: 10.1111/j.1523-5378.2009.00709.x

  13. Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study

    British Journal of Clinical Pharmacology

    Volume 80, Issue 3, September 2015, Pages: 446–459, Joel Morganroth, Yaning Wang, Michael Thorn, Yuji Kumagai, Stuart Harris, Norman Stockbridge, Robert Kleiman and Rashmi Shah

    Version of Record online : 2 JUL 2015, DOI: 10.1111/bcp.12684

  14. QT and QTc Interval With Standard and Supratherapeutic Doses of Darifenacin, a Muscarinic M3 Selective Receptor Antagonist for the Treatment of Overactive Bladder

    The Journal of Clinical Pharmacology

    Volume 45, Issue 9, September 2005, Pages: 1038–1047, Denise B. Serra, Melton B. Affrime, Martin P. Bedigian, Gerard Greig, Slavica Milosavljev, Andrej Skerjanec and Yibin Wang

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005279010

  15. You have free access to this content
    Comparative Analysis of Length of Stay, Total Costs, and Treatment Success between Intravenous Moxifloxacin 400 mg and Levofloxacin 750 mg among Hospitalized Patients with Community-Acquired Pneumonia

    Value in Health

    Volume 12, Issue 8, November/December 2009, Pages: 1135–1143, Howard Friedman, Xue Song, Simone Crespi and Prakash Navaratnam

    Version of Record online : 20 AUG 2009, DOI: 10.1111/j.1524-4733.2009.00576.x

  16. Population Pharmacokinetic and Concentration—QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies

    The Journal of Clinical Pharmacology

    Volume 51, Issue 8, August 2011, Pages: 1152–1162, Dr Jeffry A. Florian, Dr Christoffer W. Tornøe, Dr Richard Brundage, Dr Ameeta Parekh and Dr Christine E. Garnett

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010381498

  17. You have free access to this content
    Effect of Ponesimod, a Selective S1P1 Receptor Modulator, on the QT Interval in Healthy Individuals

    Basic & Clinical Pharmacology & Toxicology

    Volume 116, Issue 5, May 2015, Pages: 429–437, Matthias Hoch, Borje Darpo, Patrick Brossard, Meijian Zhou, Randall Stoltz and Jasper Dingemanse

    Version of Record online : 8 NOV 2014, DOI: 10.1111/bcpt.12336

  18. You have free access to this content
    Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile

    Clinical Microbiology and Infection

    Volume 9, Issue 6, June 2003, Pages: 526–530, G. Ackermann, Y. J. Tang-Feldman, R. Schaumann, J. P. Henderson, A. C. Rodloff, J. Silva Jr and S. H. Cohen

    Version of Record online : 24 JUN 2003, DOI: 10.1046/j.1469-0691.2003.00559.x

  19. Pharmacokinetics and Pharmacodynamic, Pharmacokinetic, Pharmacodynamic, and Electrocardiographic Effects of Dapoxetine and Moxifloxacin Compared With Placebo in Healthy Adult Male Subjects

    The Journal of Clinical Pharmacology

    Volume 49, Issue 6, June 2009, Pages: 634–642, Dr Nishit B. Modi, Dr Rajneesh Nath, Dr Peter Staehr, Dr Suneel K. Gupta, Dr Joseph W. Aquilina and Dr David Rivas

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009333486

  20. You have free access to this content
    Repeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QTc interval in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 74, Issue 2, August 2012, Pages: 296–303, Jorg Taubel, Asif Naseem, Duolao Wang, Radivoj Arezina, Ulrike Lorch and A. John Camm

    Version of Record online : 10 JUL 2012, DOI: 10.1111/j.1365-2125.2012.04190.x